GeneVentiv Therapeutics
Pre-clinicalDevelops gene therapies for rare genetic diseases using novel viral vector delivery platforms.
Founded
2019
Focus
RNA & Gene Therapy
About
Develops gene therapies for rare genetic diseases using novel viral vector delivery platforms.
Funding History
2Total raised: $23.2M
Series A$20MUndisclosedJul 15, 2023
Seed$3.2MUndisclosedNov 15, 2020
Company Info
TypePrivate
Founded2019
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile